$13.1 Million Grant Supports Bacterial Therapy Research for Resistant Breast Cancer

A $13.1 million grant is funding research led by a scientist at Weill Cornell Medicine in collaboration with the University of Massachusetts Amherst. The project focuses on engineering therapeutic Salmonella to address treatment gaps in drug-resistant triple-negative breast cancers. This effort aims to develop new bacterial therapies targeting resistant forms of breast cancer.

Originally published by gnews